Source: FINSMEs

Encycle Therapeutics: Encycle Therapeutics Completes CAD$2.85M Financing

Encycle Therapeutics, Inc., a Toronto,...

Read full article »
Encycle Therapeutics's Competitors | Encycle Therapeutics's News | Encycle Therapeutics's Financials
Stay up-to-date with the latest news on Encycle Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Jeffrey A.M. Coull's photo - President & CEO of Encycle Therapeutics

President & CEO

Jeffrey A.M. Coull

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Encycle Therapeutics